We are looking for young people 2–17 years of age to join a Crohn’s disease (CD) clinical research to help us discover more about treating IBD. If you are looking for a potential new treatment option for IBD or moderate to severe Crohn’s disease (including associated symptoms such as diarrhea with pus, persistent diarrhea, abdominal pain, frequent fevers and/or eye pain), consider one of our IBD clinical trials. All eligible participants will receive no-cost study-related care and study medication. Your child or teen 2–17 years of age may be eligible to take part.
Your child may be eligible to take part in the IBD clinical trials if they:
- are 2‒17 years of age
- have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
- have previously received treatment for UC or CD that has not worked.
Enrollment is limited, so please respond now.
